antimicrobial resistance (AMR)
-
GSK-Spero Therapeutics’ Utebzi earns FDA approval to combat rising global antimicrobial resistance
More than 3 million cases of complicated UTIs are recorded annually in the United States, and treatment failure affects up to one-third of patients.
-
JOOTRH Study warns rising antibiotic resistance is undermining wound care treatment
The study found that resistance to commonly prescribed antibiotics, including ampicillin and cotrimoxazole, now exceeds 90% in some wound infection cases.
-
Tanzania implements One Health Strategy to combat drug-resistant infections
This strategy recognizes that human health, animal health, and environmental health are interconnected and requires action across all three sectors.
-
Arcera Life Sciences partners with ISPOR UAE to combat the antimicrobial resistance crisis
In 2021 alone, bacterial AMR directly caused 1.14 million deaths worldwide. Without immediate intervention, experts forecast that bacterial AMR will claim 39 million lives over the next 25 years
-
WHX Labs 2026 Dubai to target the global threat of antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, viruses, and fungi evolve to resist medications, making infections harder to treat and increasing the risk of severe illness and death.
-
Nigeria launches a landmark survey to map the antimicrobial resistance burden and inform policy.
The survey aims to establish a national baseline on AMR prevalence, assess the distribution and burden of resistance across different regions and populations, and contribute to the global target of reducing AMR deaths by 10 percent by 2030.
-
Ethiopia launches fourth National Action Plan to combat antimicrobial resistance
Ethiopia’s updated action plan reinforces its leadership role in the continent’s fight against antimicrobial resistance (AMR).